 Buspirone effect tobacco withdrawal symptoms pilot study Tobacco withdrawal symptoms cessation pilot study buspirone new azapirone anxiolytic tobacco withdrawal Thirteen smokers open clinical trial Smokers mg/day oral buspirone weeks cessation Tobacco withdrawal Spielberger state-anxiety scales baseline quit date hours hours week weeks abrupt cessation final visit smokers withdrawal experience previous cessation attempts patients percent medication cessation smokers percent withdrawal relief definite percent moderate percent slight two-thirds smokers difficulty concentrating restlessness anxiety tobacco withdrawal attempts patients percent decreased smoking urges medication titration period Tobacco withdrawal symptoms state-anxiety scores study results encouraging caution small sample size lack placebo control Buspirone effect tobacco withdrawal symptoms randomized clinical trial